AstraZeneca's CRL on ZS-9 Reduces Near Term Commercial Risk for Veltassa and Relypsa (RLYP) - Wedbush

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/3/2026

1. KRG
2. CCH:LN
3. META
4. CCHGY
5. PRY:IM
6. PRYMY
7. SPY
8. SKA-B
9. PBA
10. ALAR

Go back to AstraZeneca's CRL on ZS-9 Reduces Near Term Commercial Risk for Veltassa and Relypsa (RLYP) - Wedbush
RELYPSA (NASDAQ: RLYP) Delayed: 31.99 --0 (-0%)
Previous Close $31.99    52 Week High $32.12 
Open $3.07    52 Week Low $10.26 
Day High $31.99    P/E N/A 
Day Low $31.99    EPS $-4.54 
Volume 79,870